Compare $MBRX vs $TOVX | Chartloom

Compare

$MBRX vs $TOVX

Moleculin Biotech Inc · Theriva Biologics Inc

MBRX

Moleculin Biotech Inc

TOVX

Theriva Biologics Inc

Compare $MBRX vs $TOVX

Comparing Moleculin Biotech Inc and Theriva Biologics Inc

MBRXMoleculin Biotech Inc

TOVXTheriva Biologics Inc

MBRXMoleculin Biotech Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-87.8%

52W performance

-96.5%

FCF yield

-811.4%

TOVXTheriva Biologics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-16.5%

52W performance

-51.8%

FCF yield

-128.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MBRX

TOVX

Detailed metrics comparison

MBRX

Moleculin Biotech Inc

TOVX

Theriva Biologics Inc

Market Cap

MBRX$3M

TOVX$10M

Enterprise Value

MBRX$-4M

TOVX$275K

Price

MBRX$0.44

TOVX$0.22

P/E Ratio

MBRXN/A

TOVXN/A

P/S Ratio

MBRX0.00x

TOVX33.19x

EV/Sales

MBRX0.00x

TOVX0.92x

EV/EBITDA

MBRX0.00x

TOVX0.00x

P/B Ratio

MBRX0.86x

TOVX0.85x

P/FCF Ratio

MBRXN/A

TOVXN/A

EV/FCF

MBRX0.16x

TOVX-0.02x

PEG Ratio

MBRXN/A

TOVXN/A

Forward P/E (NTM)

MBRXN/A

TOVXN/A

Forward P/S (NTM)

MBRXN/A

TOVXN/A

Revenue (TTM)

MBRX$0

TOVX$300K

Revenue Growth (YoY)

MBRXN/A

TOVXN/A

Forward Rev Growth

MBRX131.1%

TOVX20375.2%

Gross Margin (TTM)

MBRX0.0%

TOVX71.5%

Operating Margin (TTM)

MBRX0.0%

TOVX0.0%

EBITDA Margin (TTM)

MBRX0.0%

TOVX-3940.7%

Net Margin (TTM)

MBRX0.0%

TOVX-4376.0%

FCF Margin (TTM)

MBRXN/A

TOVX-4254.7%

Net Income (TTM)

MBRX$-33M

TOVX$-13M

FCF (TTM)

MBRX$-25M

TOVX$-13M

EPS (TTM)

MBRX-$5.73

TOVX-$0.29

ROE (TTM)

MBRX-3539.0%

TOVX-9349.0%

ROA (TTM)

MBRX-13955.0%

TOVX-3269.0%

ROIC (TTM)

MBRX-3539.0%

TOVX-8231.0%

Cash

MBRX$7M

TOVX$11M

Debt

MBRX$0

TOVX$2M

Net Cash/Debt

MBRX$7M

TOVX$10M

Current Ratio (TTM)

MBRX0.94x

TOVX1.13x

Quick Ratio (TTM)

MBRX0.78x

TOVX1.09x

Debt/Equity (TTM)

MBRX0.00x

TOVX0.14x

Debt/Assets (TTM)

MBRX0.0%

TOVX0.0%

Interest Coverage (TTM)

MBRXN/A

TOVXN/A

Net Debt/EBITDA (TTM)

MBRX0.00x

TOVX0.00x

Beta

MBRX2.10

TOVX1.25

52W Performance

MBRX-96.5%

TOVX-51.8%

YTD Performance

MBRX-87.8%

TOVX-16.5%

% from 52W High

MBRX-97.2%

TOVX-74.8%

% from 52W Low

MBRX173.9%

TOVX35.6%

Asset Turnover (TTM)

MBRX0.00x

TOVX0.01x

FCF Yield (TTM)

MBRX-811.4%

TOVX-128.2%

Earnings Yield (TTM)

MBRX-1040.8%

TOVX-131.8%

Dividend Yield (TTM)

MBRXN/A

TOVXN/A

Rule of 40

MBRX0.0

TOVX-4,254.7

EV/GP/RG

MBRXN/A

TOVX0.00

Ticker research

View MBRX research View TOVX research

Metric	MBRX Moleculin Biotech Inc	TOVX Theriva Biologics Inc
Market & Valuation
Market Cap	$3M	$10M
Enterprise Value	$-4M	$275K
Price	$0.44	$0.22
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	33.19x
EV/Sales	0.00x	0.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.86x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	-0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$300K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	131.1%	20375.2%
Profitability
Gross Margin (TTM)	0.0%	71.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3940.7%
Net Margin (TTM)	0.0%	-4376.0%
FCF Margin (TTM)	N/A	-4254.7%
Net Income (TTM)	$-33M	$-13M
FCF (TTM)	$-25M	$-13M
EPS (TTM)	-$5.73	-$0.29
ROE (TTM)	-3539.0%	-9349.0%
ROA (TTM)	-13955.0%	-3269.0%
ROIC (TTM)	-3539.0%	-8231.0%
Financial Health
Cash	$7M	$11M
Debt	$0	$2M
Net Cash/Debt	$7M	$10M
Current Ratio (TTM)	0.94x	1.13x
Quick Ratio (TTM)	0.78x	1.09x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.10	1.25
52W Performance	-96.5%	-51.8%
YTD Performance	-87.8%	-16.5%
% from 52W High	-97.2%	-74.8%
% from 52W Low	173.9%	35.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-811.4%	-128.2%
Earnings Yield (TTM)	-1040.8%	-131.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,254.7
EV/GP/RG	N/A	0.00
Ticker research	View MBRX research	View TOVX research

Valuation

P/S Ratio

MBRX

0.00x

TOVX

33.19x

EV/FCF

TOVX

-0.02x

MBRX

0.16x

Growth & revenue

Forward Revenue Growth

TOVX

20375.2%

MBRX

131.1%

Profitability & performance

Gross Margin

TOVX

71.5%

MBRX

0.0%

ROE

MBRX

-3539.0%

TOVX

-9349.0%

FCF Yield %

TOVX

-128.2%

MBRX

-811.4%

52-Week Performance

TOVX

-51.8%

MBRX

-96.5%

Detailed metrics comparison

MBRX

Moleculin Biotech Inc

TOVX

Theriva Biologics Inc

Market Cap

MBRX$3M

TOVX$10M

Enterprise Value

MBRX$-4M

TOVX$275K

Price

MBRX$0.44

TOVX$0.22

P/E Ratio

MBRXN/A

TOVXN/A

P/S Ratio

MBRX0.00x

TOVX33.19x

EV/Sales

MBRX0.00x

TOVX0.92x

EV/EBITDA

MBRX0.00x

TOVX0.00x

P/B Ratio

MBRX0.86x

TOVX0.85x

P/FCF Ratio

MBRXN/A

TOVXN/A

EV/FCF

MBRX0.16x

TOVX-0.02x

PEG Ratio

MBRXN/A

TOVXN/A

Forward P/E (NTM)

MBRXN/A

TOVXN/A

Forward P/S (NTM)

MBRXN/A

TOVXN/A

Revenue (TTM)

MBRX$0

TOVX$300K

Revenue Growth (YoY)

MBRXN/A

TOVXN/A

Forward Rev Growth

MBRX131.1%

TOVX20375.2%

Gross Margin (TTM)

MBRX0.0%

TOVX71.5%

Operating Margin (TTM)

MBRX0.0%

TOVX0.0%

EBITDA Margin (TTM)

MBRX0.0%

TOVX-3940.7%

Net Margin (TTM)

MBRX0.0%

TOVX-4376.0%

FCF Margin (TTM)

MBRXN/A

TOVX-4254.7%

Net Income (TTM)

MBRX$-33M

TOVX$-13M

FCF (TTM)

MBRX$-25M

TOVX$-13M

EPS (TTM)

MBRX-$5.73

TOVX-$0.29

ROE (TTM)

MBRX-3539.0%

TOVX-9349.0%

ROA (TTM)

MBRX-13955.0%

TOVX-3269.0%

ROIC (TTM)

MBRX-3539.0%

TOVX-8231.0%

Cash

MBRX$7M

TOVX$11M

Debt

MBRX$0

TOVX$2M

Net Cash/Debt

MBRX$7M

TOVX$10M

Current Ratio (TTM)

MBRX0.94x

TOVX1.13x

Quick Ratio (TTM)

MBRX0.78x

TOVX1.09x

Debt/Equity (TTM)

MBRX0.00x

TOVX0.14x

Debt/Assets (TTM)

MBRX0.0%

TOVX0.0%

Interest Coverage (TTM)

MBRXN/A

TOVXN/A

Net Debt/EBITDA (TTM)

MBRX0.00x

TOVX0.00x

Beta

MBRX2.10

TOVX1.25

52W Performance

MBRX-96.5%

TOVX-51.8%

YTD Performance

MBRX-87.8%

TOVX-16.5%

% from 52W High

MBRX-97.2%

TOVX-74.8%

% from 52W Low

MBRX173.9%

TOVX35.6%

Asset Turnover (TTM)

MBRX0.00x

TOVX0.01x

FCF Yield (TTM)

MBRX-811.4%

TOVX-128.2%

Earnings Yield (TTM)

MBRX-1040.8%

TOVX-131.8%

Dividend Yield (TTM)

MBRXN/A

TOVXN/A

Rule of 40

MBRX0.0

TOVX-4,254.7

EV/GP/RG

MBRXN/A

TOVX0.00

Ticker research

View MBRX research View TOVX research

Metric	MBRX Moleculin Biotech Inc	TOVX Theriva Biologics Inc
Market & Valuation
Market Cap	$3M	$10M
Enterprise Value	$-4M	$275K
Price	$0.44	$0.22
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	33.19x
EV/Sales	0.00x	0.92x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.86x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	-0.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$300K
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	131.1%	20375.2%
Profitability
Gross Margin (TTM)	0.0%	71.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3940.7%
Net Margin (TTM)	0.0%	-4376.0%
FCF Margin (TTM)	N/A	-4254.7%
Net Income (TTM)	$-33M	$-13M
FCF (TTM)	$-25M	$-13M
EPS (TTM)	-$5.73	-$0.29
ROE (TTM)	-3539.0%	-9349.0%
ROA (TTM)	-13955.0%	-3269.0%
ROIC (TTM)	-3539.0%	-8231.0%
Financial Health
Cash	$7M	$11M
Debt	$0	$2M
Net Cash/Debt	$7M	$10M
Current Ratio (TTM)	0.94x	1.13x
Quick Ratio (TTM)	0.78x	1.09x
Debt/Equity (TTM)	0.00x	0.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.10	1.25
52W Performance	-96.5%	-51.8%
YTD Performance	-87.8%	-16.5%
% from 52W High	-97.2%	-74.8%
% from 52W Low	173.9%	35.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-811.4%	-128.2%
Earnings Yield (TTM)	-1040.8%	-131.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,254.7
EV/GP/RG	N/A	0.00
Ticker research	View MBRX research	View TOVX research